Sales Growth YoY (Last 12 Months): Zymeworks Inc. (ZYME)

Public company logo of Zymeworks Biopharmaceuticals (ZYME)

The development of multi-specific antibodies and the success of zanidatamab establish a foundation for growth, as confirmed by the TTM revenue growth rate for Zymeworks Inc. (ZYME). Management's strategic focus on oncology and the launch of targeted therapies for solid tumors strengthen the financial base. Meanwhile, the 97.30 metric determines this level, capturing the final revenue dynamics relative to operating expenses.

Zymeworks (ZYME) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/16/2026

Zymeworks (ZYME) - metric breakdowns and financial figures

- company stock exchange capitalization indicators:
Summary company analytics:Zymeworks Inc.
Product sample of zymeworks.com

The development of cancer immunotherapy through strategic alliances with pharma behemoths directly impacts the rolling annual sales growth rate, reflecting the effectiveness of licensing agreements. The current value of 97.30 is calculated as the percentage deviation of TTM revenue from the same period last year, allowing investors to assess the business scaling pace and the fundamental resilience of Zymeworks Inc. (ZYME) amid industry cycles.

Competitors of Zymeworks Inc. (ZYME)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Tango Pharma (TNGX)|Revenue Growth YoY (Last 12 Months) IOVA|IMTX - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XNCR (Xencor Corp)|Revenue Change YoY (Last 12 Months) CMPX|Sales Growth YoY (TTM) REPL (Replimune)|Revenue Dynamics YoY (Last Twelve Months) LYEL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)